Long Non-coding RNA: An Emerging Contributor and Potential Therapeutic Target in Renal Fibrosis

Area of Science:

• Molecular Biology
• Nephrology
• Genomics

Background:

• Renal fibrosis (RF) leads to irreversible decline in kidney function and end-stage renal disease.
• The molecular mechanisms underlying RF are complex and not fully understood.
• Long non-coding RNAs (lncRNAs) are regulators of cellular processes implicated in disease.

Purpose of the Study:

• To review current literature on the role of lncRNAs in renal fibrosis.
• To discuss the potential of lncRNAs as diagnostic and prognostic biomarkers for RF.
• To identify lncRNAs as therapeutic targets for RF and chronic kidney disease (CKD).

Main Methods:

• Comprehensive literature review of studies on lncRNAs and RF.
• Analysis of aberrant lncRNA expression in RF development and progression.
• Evaluation of lncRNA functions in cellular homeostasis and disease.

Main Results:

• Aberrantly expressed lncRNAs are significantly involved in the development and progression of RF.
• lncRNAs have potential as diagnostic and prognostic biomarkers for RF.
• lncRNAs represent promising therapeutic targets for RF and CKD.

Conclusions:

• lncRNAs play a critical role in the pathogenesis of renal fibrosis.
• Further research into lncRNAs can lead to novel diagnostic tools and treatments for CKD.
• Targeting lncRNAs offers a promising strategy for managing renal fibrosis.